NYSCF Announces 2020 Class of NYSCF – Robertson Investigators
Top row: Drs. Raffaella Di Micco, Samantha Morris, José Ordovás-Montañés. Bottom row: Drs. Jiami Guo, David Schneider, John Tuthill New York, NY (October 20, 2020) – The...
59 Results
Clear Filters
A New Method for Studying the DNA You Only Inherit from Your Mom, and What It Reveals About Disease and Aging
The Context: Mitochondria are structures in our cells that carry their own DNA inherited only from our mothers and provide energy to help our bodies function....
Roadmap of Brain Development Offers Insight into Autism and Schizophrenia
The Context: Studying brain development can be difficult since scientists cannot easily access developing brain tissue. Creating models of human brain development from stem cells allows...
2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
How ‘Remixing’ a Gene May Lead to Schizophrenia and other Neuropsychiatric Diseases
The Context: NRXN1 is a gene that is broadly implicated in neuropsychiatric disorders such as schizophrenia, autism spectrum disorder, and epilepsy; however, the ways in which...
Precision Medicine and the Power of Stem Cells: Highlights of the 2019 NYSCF Conference
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
Genetic Variants Synergize to Confer Schizophrenia Risk
The Context: Schizophrenia has a strong genetic component. Scientists have discovered many genetic variants that may play a role in its onset, but each individual variant...
Meet LADL: A New Technology for Controlling DNA Folding
The Context: To fit inside the nucleus of our cells, our DNA crumples up, forming loops and making itself compact. When certain sequences of looped DNA...
CRISPR to the RESCUE: Gene Editing Technology Gets More Versatile
The Context: CRISPR is a powerful gene editing tool which traditionally works by locating and modifying stretches of DNA within the genome. However, this technique creates...
CRISPR Gets an Upgrade Thanks to “Jumping Genes”
The Context: CRISPR is a powerful, ‘word-processor’-like tool for editing DNA, but currently it is much easier to eliminate undesired sequences than it is to accurately...
Gene Editing: The Science, Ethics, and Promise of a Revolutionary Technology
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
NYSCF Hosts Launch of Jamie Metzl’s New Book: “Hacking Darwin: Genetic Engineering and the Future of Humanity”
“After 3.8 billion years of evolving by Darwinian principles, we are turning a corner and taking more control over all biology, including our own,” explained Jamie...
NYSCF Inks Strategic Partnership with Ngene Therapeutics
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
Why We Need Stem Cell Avatars: Susan Solomon Speaks at IGNITION Conference
“It takes 13 years—after you have sunk 4 billion dollars into a drug—to figure out whether or not it will succeed, and your chance of being...
Claims of First Gene-Edited Babies Spark Concerns
Reports this week that a researcher in China has created genetically modified children using the gene editing technology CRISPR have been met with widespread concern. Dr....
Translational Research Takes Center Stage at NYSCF Conference
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
NYSCF Announces 2018 Class of NYSCF – Robertson Investigators
NEW YORK, NY (October 23, 2018) – The New York Stem Cell Foundation (NYSCF) announced the 2018 class of NYSCF – Robertson Investigators, welcoming six of...
How Does a Glitch in Genome Folding Lead to Disease?
The sequence of bases (As, Cs, Gs, and Ts) that make up our DNA matters: it is what determines our genetic blueprint, which in turn determines...
Dr. Maria Lehtinen Elucidates the Genetics Behind Brain and Speech Development
In a new study published in Neuron, a team from Boston Children’s Hospital led by NYSCF – Robertson Neuroscience Investigator Maria Lehtinen, PhD, discovered that a...
How Can Stem Cells Help Us Understand Rare Disease?
In a new article from the patient advocacy and research nonprofit Jordan’s Guardian Angels, NYSCF speaks about its work creating induced pluripotent stem cells from patients with Jordan’s...
NYSCF Partners with ToolGen, nSAGE to Integrate Gene Editing and Stem Cell Technologies
New collaboration aims to develop better therapies New York, NY (August 1, 2018) – The New York Stem Cell Foundation (NYSCF) Research Institute today announced a...
Dr. Feng Zhang Receives Grant From G. Harold and Leila Y. Mathers Foundation
NYSCF – Robertson Investigator Feng Zhang, PhD, Core Member at the Broad Institute of MIT and Harvard and Professor of Brain and Cognitive Sciences and Biological Engineering at...
SPRITE: A New Technique For Mapping DNA In Our Nuclei
Researchers at the California Institute of Technology led by NYSCF – Robertson Investigator Mitchell Guttman, PhD, have developed a new tool called SPRITE to uncover how...
Four NYSCF Innovators Named 2018 Howard Hughes Medical Institute Investigators
This week, NYSCF – Robertson Investigators Feng Zhang, PhD (MIT), Ed Boyden, PhD (MIT), Gaby Maimon, PhD (The Rockefeller University), and Zachary Knight, PhD (University of...
NYSCF – Robertson Investigator Feng Zhang Launches “Beam Therapeutics”
NYSCF – Robertson Investigator Feng Zhang, PhD, Core Member at Broad Institute of MIT and Harvard, Professor at Massachusetts Institute of Technology, along with David Liu, PhD, Professor...